Search
for

    Sort by

    Research 271–300 of 1000+

    1. Efecto en el sangrado perioperatorio durante la resección transuretral de la próstata tras un mes de tratamiento con dutasteride Actas Urológicas Españolas · 2010
    2. Urological Oncology: Prostate Cancer 2010
    3. Slow progress in prostate cancer BJUI · 2007
    4. How not to detect prostate cancer Lancet Oncology · 2007
    5. Effects of the androgen receptor overexpression in prostate cancer 2007
    6. TRAIL sensitization of PC3 prostate cancer cells by doxorubicin can be blocked by the anti-oxidant N-acetyl-cysteine or by the iron chelator deferoxamine Clinical Cancer Research · 2006
    7. Doxetaxel: new indication. Prostate cancer: a few more weeks. PubMed · 2006
    8. RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER 2005
    9. Can we predict prostate size by scoring baldness? The relationship of androgenic alopecia and lower urinary tract symptoms Central European Journal of Urology · 2019
    10. 5α-reductase activity in the prostate Urology · 2001 · 237 citations
    11. Androgen biosynthetic pathways in the human prostate 2008 · 160 citations
    12. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients The American Journal of Medicine · 1992 · 116 citations
    13. Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study British Journal of Cancer · 2017 · 65 citations
    14. Five-alpha-reductase Inhibitors for prostate cancer prevention. The Cochrane library · 2008 · 37 citations
    15. Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis Journal of The American Academy of Dermatology · 2013 · 34 citations
    16. Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use Scandinavian journal of urology · 2016 · 29 citations
    17. Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase BJU international · 2009 · 29 citations
    18. Estimating the Contribution of the Prostate to Blood Dihydrotestosterone 2003 · 28 citations
    19. Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer Journal of the American Heart Association · 2021 · 8 citations
    20. Anti-proliferative effect of terpenes on human prostate cáncer cells: natural sources and their potential role as chemopreventive agents. Revista chilena de nutrición · 2017 · 3 citations
    21. Comparison of Intraoperative Blood Loss in Patients With Benign Prostatic Hyperplasia Undergoing Bipolar Transurethral Resection of the Prostate With and Without Preoperative Oral Finasteride Cureus · 2025 · 2 citations
    22. Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality The International Journal of Medical Science and Health Research · 2024 · 1 citations
    23. Androgen receptor-mediated gene activation in prostate cancer cells UEF eRepo (University of Eastern Finland) · 2010 · 1 citations
    24. Association between Androgenic Hair Patterns and Prostate Cancer Risk in South Indian Men: A Case-control Study from the Cauvery Delta. PubMed · 2026
    25. Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial The Journal of Urology · 2017
    26. Konvergentna validacija farmakoekonomskih aspekata terapije benigne hiperplazije prostate u Crnoj Gori National Repository of Dissertations in Serbia · 2016
    27. Faculty Opinions recommendation of Screening for prostate cancer. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2013
    28. 1452 DETECTION RATE OF CLINICALLY INSIGNIFICANT PROSTATE CANCER INCREASES WITH REPEATING PROSTATE BIOPSIES The Journal of Urology · 2012
    29. Paradigm Shift in the Concept of Hormonal Milieu of Prostate Cancer InTech eBooks · 2011
    30. S3 SERUM TRIGLYCERIDE CONCENTRATION AND RISK OF PROSTATE CANCER: A PROSPECTIVE MULTICENTER STUDY European Urology Supplements · 2010